Wegovy was approved by the FDA to reduce the risk of major cardiovascular events in obese or overweight adults with established cardiovascular disease.
Wegovy has been shown to reduce the risk of major adverse cardiac events by 20%, cardiovascular death by 15%, and death from any cause by 19%. [ more ]
DEA to reclassify marijuana as a lower-risk drug, reports say
The US Drug Enforcement Administration is poised to reclassify marijuana to a lower-risk drug category, aligning with health department recommendations and acknowledging potential medical benefits. [ more ]
F.D.A. Approves Antibiotic for Increasingly Hard-to-Treat Urinary Tract Infections
Pivmecillinam, a new antibiotic approved by the FDA for UTIs, offers a crucial solution for the increasing resistance to existing antimicrobial drugs. [ more ]
FDA approves bladder cancer treatment by Culver City company
FDA approved new bladder cancer treatment Anktiva by ImmunityBio, activating immune response in patients who didn't respond to prior therapies. [ more ]
FDA approval of cancer treatment provides new weapon against tumors
CAR-T therapy is successful in some blood cancers but not yet approved for solid tumors. Tumor-Infiltrating Lymphocytes (TIL) use immune cells from a patient's tumor for treatment. [ more ]
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
The FDA approved a new treatment, tarlatamab, for small cell lung cancer patients with limited life expectancy, showing potential with tripled life expectancy and practice-changing impact. [ more ]
Apple Watch AFib feature receives new FDA approval - can now be used in clinical studies - Wareable
The Apple Watch's AFib feature is the first 'digital health technology' to receive MMDT approval from the FDA, allowing its use in clinical studies. [ more ]
Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
Zepbound, a weight loss drug, shows potential in treating obstructive sleep apnea, with trial results prompting Eli Lilly to seek FDA approval for expanded use. [ more ]
COVID-19 Antiviral Drugs Promise Speedier Recoveries. But They're Not Available in the U.S.
Antiviral drugs that treat mild-to-moderate cases of COVID-19 are available overseas but not yet approved for use in the U.S.
A study showed that simnotrelvir, an antiviral drug available in China, shortened the recovery time for young, vaccinated individuals with COVID-19. [ more ]